Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma

1. Morschhauser, F.
2. Radford, J.
3. Van Hoof, A.
4. Vitolo, U.
5. Soubeyran, P.
6. Tilly, H.
7. Huijgens, P.C.
8. Kolstad, A.
9. D'Amore, F.
10. Diaz, M.G.
11. Petrini, M.
12. Sebban, C.
13. Zinzani, P.L.
14. Van Oers, M.H.J.
15. Van Putten, W.
16. Bischof-Delaloye, A.
17. Rohatiner, A.
18. Salles, G.
19. Kuhlmann, J.
20. Hagenbeek, A.